Literature DB >> 36058967

Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections.

O V Kotel'nikova1, Yu A Prokopenko1, A A Zinchenko1, O A Razgulyaeva1, E A Nokel'1, D M Karlinsky1, L S Zhigis2, L D Rumsh1.   

Abstract

The features of individual fragments of IgA1 protease of Neisseria meningitidis serogroup B during the formation of immunity to bacterial infections in animals and humans were studied. The antibodies to the immunogenic regions of the studied proteins are also detected in mice infected with some bacterial pathogens and in humans with bacterial meningitis. A region of IgA1 protease was identified that is not capable of producing antibodies during immunization of animals, but that detects homologous antibodies in the blood of humans and animals recovered from bacterial infections. It has been suggested that this fragment plays a regulatory role in the process of immunogenesis.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  IgA1 protease; bacterial infections; immunogenicity; recombinant proteins

Mesh:

Substances:

Year:  2022        PMID: 36058967     DOI: 10.1007/s10517-022-05580-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  11 in total

1.  Breast cancer statistics, 2019.

Authors:  Carol E DeSantis; Jiemin Ma; Mia M Gaudet; Lisa A Newman; Kimberly D Miller; Ann Goding Sauer; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-10-02       Impact factor: 508.702

Review 2.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

3.  Phenotypical Characteristics of Chemically Induced Mammary Tumor.

Authors:  A V Kabakov; A P Lykov; D V Morozov; O V Kazakov; A F Poveshchenko; T V Raiter; D N Strunkin; V I Konenkov
Journal:  Bull Exp Biol Med       Date:  2017-08-29       Impact factor: 0.804

Review 4.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

Authors:  Nancy L Oleinick; Rachel L Morris; Irina Belichenko
Journal:  Photochem Photobiol Sci       Date:  2002-01       Impact factor: 3.982

Review 5.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Authors:  Gloria Bertoli; Claudia Cava; Isabella Castiglioni
Journal:  Theranostics       Date:  2015-07-13       Impact factor: 11.556

6.  Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer.

Authors:  Makoto Abue; Misa Yokoyama; Rie Shibuya; Keiichi Tamai; Kazunori Yamaguchi; Ikuro Sato; Nobuyuki Tanaka; Shin Hamada; Tooru Shimosegawa; Kazuo Sugamura; Kennichi Satoh
Journal:  Int J Oncol       Date:  2014-11-10       Impact factor: 5.650

Review 7.  Immunological aspects of antitumor photodynamic therapy outcome.

Authors:  Małgorzata Wachowska; Angelika Muchowicz; Urszula Demkow
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

8.  Photodynamic Therapy (PDT): PDT Mechanisms.

Authors:  Ron R Allison; Keyvan Moghissi
Journal:  Clin Endosc       Date:  2013-01-31

Review 9.  Role of MicroRNAs-221/222 in Digestive Systems.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki
Journal:  J Clin Med       Date:  2015-08-06       Impact factor: 4.241

10.  Theranostic application of miR-429 in HER2+ breast cancer.

Authors:  Claudia Cava; Chiara Novello; Cristina Martelli; Alessia Lodico; Luisa Ottobrini; Francesca Piccotti; Marta Truffi; Fabio Corsi; Gloria Bertoli; Isabella Castiglioni
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.